Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice.Molecular Psychiatry · 2026-07-06Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-04-30Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under PsilocybinUnknown journal · 2026-04-07Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trialJournal of Affective Disorders · 2026-02-15Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compoundsJournal of Psychopharmacology · 2026-02-04Methodological moderators of psilocybin-assisted therapy in depression: A systematic review and meta-analysisNeuroscience & Biobehavioral Reviews · 2026-01-23The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysisBMC Psychology · 2026-01-01Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-12-08Unexpected Detection of Psilocybin in a 100 mg Tramadol Tablet: A Forensic Case ReportDOAJ (DOAJ: Directory of Open Access Journals) · 2025-11-30Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacy: A Scoping ReviewQeios · 2025-11-20Psilocybin in Alcohol Use Disorder Maintains Abstinence Efficacity: A Scoping ReviewPreprints.org · 2025-10-16Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depressionGeneral Hospital Psychiatry · 2025-10-10S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialPLoS Medicine · 2025-09-18“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group TherapyPsychedelic Medicine · 2025-08-24Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autismMagna Scientia Advanced Research and Reviews · 2025-06-27The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.Neuroscience and biobehavioral reviews · 2025-04-30Exploring Factors Affecting Psychological Flexibility After Psychedelic Experiences.Journal of psychoactive drugs · 2025-04-24Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathwayNaunyn-Schmiedeberg s Archives of Pharmacology · 2025-04-14Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-02-24Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey.Unknown journal · 2025-02-23Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDiJournal of the American Society for Mass Spectrometry · 2025-02-02What are the benefits and harms of classical psychedelics (psilocybin and LSD) for treating anxiety, depression, and existential distress in people with life-threatening diseases?Cochrane Clinical Answers · 2025-01-12Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case reportPalliative & Supportive Care · 2024-12-31Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04Impact of psilocybin on cognitive function: A systematic review.Unknown journal · 2024-09-30Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant responseJournal of Psychopharmacology · 2024-09-19Prevalence and Correlates of Psychedelic Use in Poland: A Study on a Representative Sample of Polish AdultsResearch Square · 2024-08-14Psilocybin legislation is helping psychedelic drugs make a comeback - a drug researcher explains the challenges they faceUnknown journal · 2024-08-01Psilocybin desynchronizes the human brainNature · 2024-07-16Differing Approaches to Investigating the Therapeutic Efficacy of Psilocybin Across Diverse IndicationsDrug and Alcohol Dependence · 2024-06-30The effect of psychedelics on the level of brain-derived neurotrophic factor: A systematic review and meta-analysis.Journal of psychopharmacology (Oxford, England) · 2024-04-30Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.Psychiatry research · 2024-04-30Mechanisms of therapeutic change after psychedelic treatment in OCDPsychiatry Research · 2024-04-06Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysisCancer · 2023-12-17The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.Unknown journal · 2023-10-29Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSDJournal of Psychoactive Drugs · 2023-08-30Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapyJournal of Psychedelic Studies · 2023-08-20On the mushrooming reports of “quiet quitting”: Employees’ lifetime psilocybin use predicts their overtime hours workedJournal of Psychoactive Drugs · 2023-07-30Trip Where you Stand: Towards Psychedelic LiberationFeminist Review · 2023-06-30HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With CancerJournal of Pain and Symptom Management · 2023-06-09Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trialJournal of Psychedelic Studies · 2023-01-17Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeismJournal of Psychedelic Studies · 2023-01-15A Review of Synthetic Access to Therapeutic Compounds Extracted from.Pharmaceuticals (Basel, Switzerland) · 2022-12-27Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case reportHeliyon · 2022-11-30Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)Journal of Anesthesiology and Pain Therapy · 2022-10-02Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.The International Journal of Neuropsychopharmacology · 2022-03-31Counselors’ attitudes toward psychedelics and their use in therapyJournal of Counseling & Development · 2022-03-18Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.Translational Psychiatry · 2022-02-22Is MDD the right target for early-stage psychedelic-assisted therapy trials?Journal of Psychedelic Studies · 2021-09-14Effects of Ayahuasca on Personality: Results of Two Randomized, Placebo-Controlled Trials in Healthy Volunteers.Frontiers in Psychiatry · 2021-08-05Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review.Journal of psychiatric research · 2021-04-30Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.Journal of Clinical Psychopharmacology · 2021-04-30[Efficacy of psychedelics in psychiatry, a systematic review of the literature].Unknown journal · 2021-04-19A Trip Through Employment Law: Protecting Therapeutic Psilocybin Users in the Workplace.PubMed · 2020-12-31Describing the Unspeakable: Psychedelic Communication Technologies and the Development of a Posthuman LanguageJournal of Posthuman Studies · 2020-11-30Efficacy of psychedelic treatments on depressive symptoms: A meta-analysis.Journal of psychopharmacology (Oxford, England) · 2020-09-30These fungi drug cicadas with psilocybin or amphetamine to make them mate nonstopAccess Science · 2018-12-31Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.Psychopharmacology · 2017-11-07Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOIPsychopharmacology · 2008-07-04Persistent psychiatric symptoms after eating psilocybin mushrooms.Unknown journal · 1979-04-30[Studies on hallucinogens. V. Synthesis of psilocybin].Unknown journal · 1973-12-31[Studies on hallucinogens. 3. Synthesis of psilocin (author's transl)].Unknown journal · 1972-12-31